21 phenotypes from 3 alleles in 5 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Akt3Nmf350/Akt3+ C57BL/6J-Akt3Nmf350	abnormal seizure response to electrical stimulation	J:169028
	increased brain size	J:169028
	increased brain weight	J:169028
	increased susceptibility to pharmacologically induced seizures	J:169028
	maximal tonic hindlimb extension seizures	J:169028
	sporadic seizures	J:169028
	tonic-clonic seizures	J:169028
Akt3Nmf350/Akt3Nmf350 C57BL/6J-Akt3Nmf350	abnormal neuron morphology	J:169028
	abnormal seizure response to electrical stimulation	J:169028
	absent corpus callosum	J:169028
	ectopic cerebellar granule cells	J:169028
	enlarged hippocampus	J:169028
	increased brain size	J:169028
	increased brain weight	J:169028
	increased susceptibility to pharmacologically induced seizures	J:169028
	maximal tonic hindlimb extension seizures	J:169028
	tonic-clonic seizures	J:169028
Akt3tm1Hem/Akt3tm1Hem involves: 129P2/OlaHsd * C57BL/6	abnormal brain ventricle morphology	J:98804
	decreased brain size	J:98804
	decreased brain weight	J:98804
	decreased corpus callosum size	J:98804
	increased susceptibility to neuronal excitotoxicity	J:98804
Akt3tm1Mbb/Akt3+ B6.Cg-Akt3tm1Mbb	decreased brain size	J:245549
Akt3tm1Mbb/Akt3tm1Mbb B6.Cg-Akt3tm1Mbb	abnormal spatial reference memory	J:245549
	decreased brain size	J:245549
	impaired discrimination learning	J:245549
	increased locomotor activity	J:245549
Akt3tm1Mbb/Akt3tm1Mbb involves: C57BL/6J	abnormal seizure response to electrical stimulation	J:169028
	maximal tonic hindlimb extension seizures	J:169028
	tonic-clonic seizures	J:169028
Akt3tm1Mbb/Akt3tm1Mbb Not Specified	decreased brain size	J:96823
	normal homeostasis/metabolism phenotype	J:96823
	normal immune system phenotype	J:135903